Conexeu Sciences Inc. has created the first ever 3D-printed structures made entirely from its patented, functional extracellular matrix (ECM).
Using this platform, the Company has printed bovine-derived, collagen-based scaffolds that behave like real tissue.
“The ability to print a functional collagen-based extracellular matrix that behaves like the architecture of real tissue, versus synthetic polymers or non-functional collagens, represents a new step for regenerative medicine,” says Claudia Chavez-Munoz, MD, PhD, Chief Science Officer of Conexeu, in a news release. “By showing that CXU can print tissue structures, we are opening the door to truly personalized implants and grafts. Data has shown that CXU is a material that the body recognizes as its own. This could be a game changer in the fields of aesthetics and tissue reconstruction.”
If approved by the U.S. Food and Drug Administration (FDA), this may pave the way toward personalized implants and grafts and vascular-supportive microenvironments.
“This breakthrough is a declaration,” adds Miles Harrison, President & CEO of Conexeu. “The future of medicine is not just repairing tissue; it is creating it. With CXU, we can inject regeneration today, and we can design regeneration for tomorrow. This is the dawn of personalized tissue on demand. CXU prints with precision but lives like biology, and it sets the stage for a completely new era of human reconstruction.”
